Similar articles

• Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.

  Reinisch W, Stange EF; International AZT-2 Study Group. Reinisch W, et al. Gut. 2011 May;60(5):739-40. doi: 10.1136/gut.2010.226928. Epub 2011 Mar 1. Gut. 2011. PMID: 21363886 No abstract available.
• Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.

  Reinisch W, Angelberger S, Petritsch W, Shonova O, Lukas M, Bar-Meir S, Teml A, Schaeffeler E, Schwab M, Dilger K, Greinwald R, Mueller R, Stange EF, Herrlinger KR; International AZT-2 Study Group. Reinisch W, et al. Gut. 2010 Jun;59(6):752-9. doi: 10.1136/gut.2009.194159. Gut. 2010. PMID: 20551460 Clinical Trial.
• [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].

  Nos P, Hinojosa J, Aguilera V, Molés JR, Pastor M, Ponce J, Berenguer J. Nos P, et al. Gastroenterol Hepatol. 2000 Oct;23(8):374-8. Gastroenterol Hepatol. 2000. PMID: 11227650 Spanish.
• [Can the postoperative relapse of Crohn disease be influenced?].

  Jussila A, Färkkilä M, Järvinen HJ. Jussila A, et al. Duodecim. 2001;117(8):817-22; quiz 822, 857. Duodecim. 2001. PMID: 12116447 Review. Finnish. No abstract available.
• [Drug therapy of Crohn disease].

  Niemelä S. Niemelä S. Duodecim. 2001;117(8):807-14. Duodecim. 2001. PMID: 12116446 Review. Finnish. No abstract available.